We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Burning Rock Biotech Ltd | LSE:BNR | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.35 | 0 | 01:00:00 |
TIDMBNR
RNS Number : 7221D
Blenheim Natural Resources PLC
28 April 2017
28 April 2017
BLENHEIM NATURAL RESOURCES PLC
("Blenheim" or the "Company")
Result of General Meeting
Blenheim is pleased to announce that at the Company's General Meeting held earlier today, both resolutions were duly passed.
As a result, shareholders have granted the directors the authority to allot and issue up to 75,000,000 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares"), (the "Consideration Shares"), as partial consideration for the conditional acquisition of a 30 per cent interest in Nashwan Holdings Ltd ("Nashwan"), as announced by the Company on 30 March 2017. The remaining consideration for the investment in Nashwan is GBP200,000 in cash (the "Cash Consideration"). Completion of the Company's investment in Nashwan was conditional on shareholders granting the directors the authority to allot and issue the Consideration Shares and will now take place within 5 business days.
Pursuant to the terms of the acquisition, the issue of the Consideration Shares and the payment of the Cash Consideration to Mr Harry Sutherland remains conditional on Nashwan successfully being granted with exploration licences over both its Menianbala and Djidje projects within 90 days of the date of completion, or by such other date agreed between the parties. Blenheim will make further announcements in this respect in due course.
Shareholders have also granted the directors the authority to allot and issue Ordinary Shares on a non-pre-emptive basis up to an aggregate nominal amount of GBP398,577. Accordingly, the Company now has the requisite authority to complete the conditional placing of 222,222,222 Ordinary Shares to raise GBP1 million before expenses, and to issue 11,111,111 warrants over Ordinary Shares to Cornhill Capital Limited, the Company's broker (announced on 27 April 2017).
Application has been made for 222,222,222 new Ordinary Shares, which rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading on the AIM Market of the London Stock Exchange ("AIM"). Dealings on AIM are expected to commence at 8:00 a.m. on or around 3 May 2017 ("Admission").
Further to the announcement of 27 April 2017, and pursuant to the authorities granted by shareholders at the Company's general meeting of shareholders held on 7 February 2017, GBP1 of the proceeds of the placing, having been raised for this specific purpose, shall be used by the Company to redeem in total the 23,790 deferred shares of GBP49 each in the capital of the Company in issue (the "Deferred Shares"). The Deferred Shares carry no voting rights and have effectively no economic value. The redemption of the Deferred Shares will be completed as soon as reasonably practicable following Admission.
Total Voting Rights
Following Admission, the issued share capital of the Company will comprise 620,798,836 Ordinary Shares with voting rights attached (one vote per share). The Company does not hold any shares in treasury. This figure of 620,798,836 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Ends
For further information please contact:
Chris Ells Blenheim Natural Resources Plc +44 (0) 1622 844601 Colin Aaronson/Jamie Barklem/ Daniel Bush Grant Thornton UK LLP +44 (0) 20 7383 5100 Nick Emerson SI Capital Ltd +44 (0)1483 413500 Lucy Williams / Duncan Vasey Peterhouse Corporate Finance Limited +44 (0) 20 7469 0932 Colin Rowbury Cornhill Capital Limited +44 (0) 20 7710 9610
The information contained within this announcement is considered to be inside information, for the purposes of Article 7 of EU Regulation 596/2014, prior to its release.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGLVLFLDZFXBBZ
(END) Dow Jones Newswires
April 28, 2017 08:38 ET (12:38 GMT)
1 Year Burning Rock Biotech Chart |
1 Month Burning Rock Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions